Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single Blind, Positive Parallel Controlled, Multicenter, Phase III Clinical Trial of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergencies

NCT04670809 is registered in ClinicalTrials.gov with Nanjing Yoko Biomedical Co., Ltd. as lead sponsor.

NCT NCT04670809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04670809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single Blind, Positive Parallel Controlled, Multicenter, Phase III Clinical Trial of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergencies
Lead sponsor
Nanjing Yoko Biomedical Co., Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
July 27, 2020
Completion date
December 31, 2021
Enrollment
262 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertensive emergency